Testing home air for radon to improve lung cancer prevention
Official title: Co-developing and Pilot Testing a Risk-tailored, Technology-supported Intervention to Increase Home Radon Testing in New Hampshire and Vermont
Run by Dartmouth-Hitchcock Medical Center · NCT05833334 · Data updated 2026-11-12
This study is trying to see if different ways of encouraging people, especially smokers and non-smokers, to test their homes for radon can help prevent lung cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 172 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 1 site (Lebanon, New Hampshire) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | August 24, 2027 |
| Study ends | August 24, 2027 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT05833334 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who rent or own their homes in New Hampshire or Vermont and have not previously tested their homes for radon.
✕Probably not a fit
Patients who have already tested their homes for radon or do not reside in New Hampshire or Vermont may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on understanding the attitudes and plans of renters and homeowners regarding radon testing in their homes. It consists of two phases: the first phase involves surveys and focus group discussions to gauge participants' views on radon testing and its impact on their testing plans. The second phase is a pilot intervention that tests various strategies to encourage radon testing among smokers and non-smokers. The study aims to evaluate the effectiveness of these interventions and the recruitment strategy within a specified timeframe.
Why it matters
Potential benefit: If successful, this study could lead to increased awareness and testing for radon, potentially reducing lung cancer risk among participants.
How similar studies have gone: Other studies have shown success in using educational interventions to promote health behavior changes, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be at least 18 years old * Have a valid mailing address in New Hampshire or Vermont, * Have not tested their current homes for radon, * Rent or own their home, and * Live at their home year-round Exclusion Criteria: * N/A
Where it's running
-
Dartmouth Cancer Center
Lebanon, New Hampshire, United States Recruiting
Study contacts
- Principal investigator: Judith R Rees, BM, BCh, PhD — Dartmouth-Hitchcock Medical Center
- Study coordinator: Stephanie Papas, MPH
- Email: Stephanie.Papas@dartmouth.edu
- Phone: 603-646-5824
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.